Clinical Trial Update: Study of NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 study of NGX-4010 for postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: Peripheral Nervous System Diseases, Pain | Phase 3 | Status: COMPLETED